skip to content »

Neurology

Houston, Texas

The Cullen Building at Baylor College of Medicine.
Department of Neurology
not shown on screen

Pantea Zohrevand, M.D.

Clinical Neurophysiology / Epilepsy Clinical Fellow (Year 1)

Medical School

M.D., Tehran University of Medical Sciences, Tehran, Iran

Internship

Internal Medicine, University of Texas, Medical Branch at Galveston, Texas

Residency

Neurology, University of Texas, Medical Branch at Galveston, Texas

Contact Information

Pantea Zohrevand, M.D.
Department of Neurology
Baylor College of Medicine
One Baylor Plaza, MS NB302
Houston, Texas 77030

Email:

Journal Publications

  • Sarial S, Shokrgozar MA, Amirzargar A, Shokri F, Radfar J, Zohrevand P, et al. IL-1, IL-1R and TNFalpha gene polymorphisms in Iranian patients with multiple sclerosis. Iran J Allergy Asthma Immunol. 2008;7(1):37-40. [View journal article]
  • Esfehaniyan F, Nakhjavani M, Safavi M, Kalbasi M, Zohrevand P. Prevalence of diabetes among under-hemodialysis-patients in 10 hemodialysis centers in Tehran. Iranian J Diabetes Lipid Disord. 2005;4(2):36-9. [View journal article]

Poster and Platform Presentations

  • Zohrevand P, Loghin M. Transient leukoencephalopathy after intrathecal chemotherapy mimicking stroke. Neurology. 2012;78(Meeting Abstracts 1):P06.016.
  • Zohrevand P, Tummala S. Nonconvulsive seizure in post stem cell transplant patients. Neurology. 2012;78(Meeting Abstracts 1):P06.017.
  • Lotfi J, Zohrevand P, Heshmat A, Sahraian M, Parsi H, Bagheri M. Menstrual disorders in multiple sclerosis patients receiving interferon-beta. Presented at the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS), 22nd Congress in Madrid, Spain (Sept. 27-30, 2006).
  • Lotfi J, Parsi H, Zohrevand P, Alikhani K, Sahraian M. Multiple sclerosis in Iran: a demographic study of 5,000 patients. J Neurol. 2006;253 Suppl 2:II/81.
  • Parsi H, Lotfi J, Sahraian M, Zohrevand P, Heshmat A. Marriage and multiple sclerosis. Presented at the 2nd International Congress on Multiple Sclerosis, Tehran, Iran (Nov. 20, 2005).
  • Sahraian M, Mottamedi M, Parsi H, Zohrevand P, Heshmat A. Vaccination in multiple sclerosis: vice or virtue (articles review). Presented at the 2nd International Congress on Multiple Sclerosis, Tehran, Iran (Nov. 20, 2005).
  • Zohrevand P, Alikhani K, Parsi H, Heshmat A. Multiple sclerosis and education: a demographic study. Presented at the 2nd International Congress on Multiple Sclerosis, Tehran, Iran (Nov. 20, 2005).
  • Zohrevand P, Esfehaniyan F, Nakhjavani M. Comparison of predisposing factors of DKA in two studies. Presented at the 16th Congress of Iranian Internal Medicine, Tehran, Iran (May 2005). [Oral Presentation]
  • Heshmat A, Najafi I, Moghadam K, Iravani M, Yunesiyan M, Zohrevand P. Effectiveness of metronidazole on cyclosporine-induced gingival hyperplasia in bone marrow and kidney transplant patients: a prospective, double-blinded controlled clinical trial. Presented at the 2nd World Congress of Nephrology, Organised jointly with ISN, ESPN, EKRA, GfN and DAGKN in Berlin, Germany (June 8-12, 2003).

E-mail this page to a friend